“The simplSEQ workflow offers many workflow advantages over other methods of cell-free DNA extraction especially speed, simplicity, reproducibility, which are

Company Filed Second Patent Application to Extend Core Technology Applications



Murrieta Genomics is pleased to announce that U.S. Patent and Trademark

Murrieta Genomics, the launch pad for genomic sequencing startups, is pleased to announce that simplSEQ, an incubator company and subsidiary,

“Our first product is a kit for the purification and isolation of nucleic acids from plasma that we believe will